THE BIOTECH GROWTH TRUST PLC
Results of the
Annual General Meeting
The following resolutions were passed
at the Annual General Meeting of the Company held on Wednesday,
15 July 2020 and the level of proxy
votes received is shown below.
Resolutions |
Votes For |
% |
Votes Against |
% |
Total Votes Cast |
Votes
Withheld* |
Ordinary Business |
|
|
|
|
|
|
1.To accept the audited accounts and
the Report of the Directors for the year ended 31 March 2020. |
15,692,683 |
100.00% |
154 |
0.00% |
15,692,837 |
1,116 |
2.To approve the
Directors’ Remuneration Report. |
15,681,025 |
99.94% |
9,370 |
0.06% |
15,690,395 |
3,558 |
3.To approve the
Directors’ Remuneration Policy. |
15,682,095 |
99.95% |
8,300 |
0.05% |
15,690,395 |
3,558 |
4.To re-elect Mr Andrew Joy as a
Director of the Company. |
15,689,111 |
100.00% |
296 |
0.00% |
15,689,407 |
4,546 |
5.To re-elect Professor Dame Kay
Davies CBE as a Director of the Company. |
15,689,688 |
99.99% |
1,402 |
0.01% |
15,691,090 |
2,863 |
6.To re-elect Mr Steve Bates as a
Director of the Company. |
15,689,253 |
100.00% |
154 |
0.00% |
15,689,407 |
4,546 |
7.To re-elect The Rt Hon Lord
Willetts as a Director of the Company. |
14,607,129 |
93.09% |
1,084,543 |
6.91% |
15,691,672 |
2,280 |
8.To re-elect Mrs Julia Le Blan as a
Director of the Company. |
15,688,452 |
100.00% |
296 |
0.00% |
15,688,748 |
5,205 |
9.To re-elect Mr Geoff Hsu as a
Director of the Company. |
14,614,147 |
93.15% |
1,075,417 |
6.85% |
15,689,564 |
4,388 |
10.To appoint BDO LLP as auditor and
to authorise the Audit Committee to determine their
remuneration. |
15,682,455 |
99.93% |
10,385 |
0.07% |
15,692,840 |
1,113 |
Special Business |
|
|
|
|
|
|
11.To authorise the Directors to
allot securities in the Company. (Ordinary Resolution) |
15,678,178 |
99.91% |
14,222 |
0.09% |
15,692,400 |
1,553 |
12. To disapply the rights of
pre-emption in relation to the allotment of securities. (Special
Resolution) |
15,659,934 |
99.81% |
29,993 |
0.19% |
15,689,927 |
4,026 |
13. To authorise the Company to make
market purchases of Ordinary shares in the Company. (Special
Resolution) |
15,682,532 |
99.93% |
10,365 |
0.07% |
15,692,897 |
1,055 |
14. That the Directors
be permitted to hold General Meetings (excluding the AGM) on not
less than 14 clear days’ notice. (Special Resolution) |
15,626,052 |
99.57% |
67,232 |
0.43% |
15,693,284 |
669 |
15. To approve the continuance of
the Company as an investment trust for a further period of five
years. |
14,621,155 |
99.99% |
1,587 |
0.01% |
14,622,742 |
1,071,211 |
* Please note that ‘Vote withheld’ is not a vote in law and is
not counted in the calculation of the proportion of votes ‘For’ and
‘Against ‘a resolution.
Any proxy votes which are at the discretion of the Chair of the
Meeting have been included in the "for" total. A vote withheld is
not a vote in law and is not counted in the calculations of votes
cast by proxy.
At the date of the AGM the total number of Ordinary shares of
25p each in issue and the total number of voting rights was
39,332,269.
The proxy voting figures will shortly also be available on the
Company’s website at http://www.biotechgt.com/
In accordance with Listing Rule 9.6.2, the full text of the
special business resolution passed has been submitted to the
National Storage Mechanism and will shortly be available for
inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The special
business resolutions will additionally be filed at Companies
House.
15 July 2020
For further information please contact:
Mark Pope Frostrow
Capital LLP – Company
Secretary 020 3 008
4913